Key facts
- COMMODORE CAPITAL is a hedge fund based in NEW YORK, NY with 2 tracked portfolio companies.
- Notable positions include Korsana Biosciences, SeraGene Therapeutics.
- COMMODORE CAPITAL reports $724.9M in regulatory assets under management across 1 private fund, per its SEC Form ADV (2026-03).
Registered with the SEC
Form ADV · 2026-03 · CRD 304370- Regulatory AUM
- $724.9M
- Private fund assets
- $2.4B
- Private funds
- 1 · 1 hedge
- Staff
- 12
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as COMMODORE CAPITAL LP).
Free account
See the whole book
- ·Watchlist + alerts for COMMODORE CAPITAL's activity
Create free account
No card required
Portfolio, priced
2 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Korsana Biosciences | — | $243.5M | — | |
| SeraGene Therapeutics | — | — | — |
Frequently asked
- What companies does COMMODORE CAPITAL invest in?
- COMMODORE CAPITAL has 2 recorded portfolio companies, including Korsana Biosciences, SeraGene Therapeutics.
- What is COMMODORE CAPITAL's AUM?
- COMMODORE CAPITAL manages approximately $724.9M in assets.